Literature DB >> 19499187

Reversible cardiogenic shock following 5-fluorouracil infusion.

Charles Ferté1, Carlos Gomez Roca, Yohann Loriot, Rastislav Bahleda, Cristian Moldovan, Ariel Cohen, Hassan Izzedine, Jean-Charles Soria, Stephane Ederhy.   

Abstract

5-Fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19499187     DOI： 10.1007/s10637-009-9271-3

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


  18 in total

1.  Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil.

Authors:  E Van Cutsem; P M Hoff; J L Blum; M Abt; B Osterwalder
Journal:  Ann Oncol       Date:  2002-03       Impact factor: 32.976

2.  Symptomatic cardiotoxicity associated with 5-fluorouracil.

Authors:  C C Meyer; K A Calis; L B Burke; C A Walawander; T H Grasela
Journal:  Pharmacotherapy       Date:  1997 Jul-Aug       Impact factor: 4.705

3.  Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.

Authors:  Annelieke K Peters; Margino Steemans; Erik Hansen; Natalie Mesens; Geert R Verheyen; Philippe Vanparys
Journal:  Toxicol Sci       Date:  2008-06-30       Impact factor: 4.849

4.  Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: a one-year follow-up study.

Authors:  A M Grandi; G Pinotti; E Morandi; P Zanzi; P Bulgheroni; L Guasti; A Bertolini; A Venco
Journal:  Ann Oncol       Date:  1997-07       Impact factor: 32.976

5.  A rapid assay for mitochondrial DNA damage and respiratory chain inhibition in the yeast Saccharomyces cerevisiae.

Authors:  B J Barclay; C L DeHaan; U G Hennig; O Iavorovska; R W von Borstel; R C von Borstel
Journal:  Environ Mol Mutagen       Date:  2001       Impact factor: 3.216

Review 6.  [Cardiotoxicity of 5-fluorouracil].

Authors:  Luis Teixeira; Sonia Barry; Philippe Debourdeau; Ariel Cohen; Christophe Tournigand
Journal:  Bull Cancer       Date:  2004-11       Impact factor: 1.276

7.  A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction.

Authors:  Y Mizuno; Y Hokamura; T Kimura; Y Kimura; K Kaikita; H Yasue
Journal:  Jpn Circ J       Date:  1995-05

8.  In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.

Authors:  M Mosseri; H J Fingert; L Varticovski; S Chokshi; J M Isner
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

9.  Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.

Authors:  C Porta; M Moroni; S Ferrari; G Nastasi
Journal:  Neoplasma       Date:  1998       Impact factor: 2.575

10.  The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits.

Authors:  M Cwikiel; J Eskilsson; J B Wieslander; U Stjernquist; M Albertsson
Journal:  Scanning Microsc       Date:  1996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.